 |
 |
News Stories
Name: Top Stories
REDUCE-IT Cardiovascular Outcomes Trial Reveals Significant Reduction in Major Cardiovascular Events
Nov. 10, 2018
CHICAGO ‒ The REDUCE-IT cardiovascular outcomes trial results, announced today at the American Heart Association Scientific Sessions in Chicago, met its primary composite endpoint and revealed a reduction in major adverse cardiovascular events (MACE) of 25%.
Download the manuscript online now.
Name: Members in the News
Nov. 10, 2018
NLA among 12 organizations to co-author, endorse key document for reducing risk of atherosclerotic cardiovascular disease
Name: NLA News